J J: Arthritis Drug Has Blood Cancer Risk (Reuters) Reuters - Johnson   Johnson  is warning\doctors that patients taking its rheumatoid arthritis drug\Remicade may have a higher risk of lymphoma, a blood cancer,\the company said on Friday.